Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Dermatology | Oncology | Journal

Back to Journal Articles

Sentinel Lymph Node Biopsy Staging for Melanoma Reviewed

Last Updated: July 10, 2012.

 

Routine use of SLN biopsy is recommended for accurate staging of intermediate-thickness melanoma

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
For most patients with newly diagnosed melanoma, sentinel lymph node biopsy is an acceptable method for lymph node staging, according to research published online July 9 in the Journal of Clinical Oncology.

TUESDAY, July 10 (HealthDay News) -- For most patients with newly diagnosed melanoma, sentinel lymph node (SLN) biopsy is an acceptable method for lymph node staging, according to research published online July 9 in the Journal of Clinical Oncology.

Sandra L. Wong, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a systematic review of the literature, from January 1990 through August 2011, to provide an evidence-based guideline on the use of lymphatic mapping and SLN biopsy in staging patients with newly diagnosed melanoma. The evidence was reviewed and recommendations were developed.

The researchers identified 73 studies that met the eligibility criteria. For most patients with newly diagnosed melanoma, SLN biopsy was found to be an acceptable method for lymph node staging. For any anatomic site, SLN biopsy was recommended for patients with intermediate-thickness melanomas and provided accurate staging; SLN biopsy may be recommended for staging purposes and to facilitate regional control of disease for patients with thick melanomas; for patients with thin melanomas there was insufficient evidence to support routine SLN biopsy, although it may be considered in patients with high-risk features. For patients with a positive SLN biopsy, completion lymph node dissection was recommended and achieved good regional control of disease.

"There is a need for future clinical trials to address many unresolved research questions related to the use of SLN biopsy in patients with melanoma," the authors write. "Answers to questions like these will assist clinicians and patients with making decisions and ultimately help to identify patients who may avoid expensive and intrusive procedures in staging and follow-up."

Abstract
Full Text

Copyright © 2012 HealthDay. All rights reserved.


Previous: Meditation Training May Lower Respiratory Illness Burden Next: Reducing Sedentary Behavior Could Increase Life Expectancy

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.